GLCGX
Price
$33.83
Change
-$0.02 (-0.06%)
Updated
Sep 5 closing price
Net Assets
1.56B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

GLCGX vs RGEBX

Header iconGLCGX vs RGEBX Comparison
Open Charts GLCGX vs RGEBXBanner chart's image
Goldman Sachs Large Cap Gr Insghts A
Price$33.83
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets1.56B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
GLCGX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GLCGX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLCGX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. GLCGX (1.56B). GLCGX (0.00) and RGEBX (0.00) have matching dividends . GLCGX was incepted earlier than RGEBX: GLCGX (28 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than GLCGX (0.95). GLCGX is a more actively managed with annual turnover of: 215.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than GLCGX: RGEBX (250) vs GLCGX (1000). RGEBX annual gain was more profitable for investors over the last year : 17.59 vs. GLCGX (10.34). RGEBX return over 5 years is better than : 38.71 vs. GLCGX (-13.40).
GLCGXRGEBXGLCGX / RGEBX
Total Expense Ratio0.921.0984%
Annual Report Gross Expense Ratio0.951.0987%
Fund Existence28 years11 years-
Gain YTD9.58915.39862%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B332B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.3417.5959%
Returns for 3 years31.0957.6154%
Returns for 5 years-13.4038.71-35%
Returns for 10 years56.3991.4462%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd